13F Holdings
中文EN

KRMD KORU Medical Systems, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 704440 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY18.4%
TTM net income YoY77.8%
TTM EPS YoY92.9%
Revenue 3-yr CAGR17.3%
Net income 3-yr CAGR—

Margins

Gross margin63.6%
Operating margin-1.3%
Net margin-1.8%
FCF margin-0.8%
EBITDA margin0.4%

Returns

ROE-4.6%
ROA-2.9%
ROIC (approx.)-4.7%
Asset turnover1.66x

Leverage & solvency

Liabilities / assets32.6%
Debt / equity0.00x
Current ratio2.97x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.54x
Accruals ratio-4.5%
Payout ratio—
Capex / revenue1.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$41.13M$33.65M$28.52M$27.90M$23.49M
Cost of revenue$15.52M$12.31M$11.81M$12.53M$9.72M
Gross profit$25.60M$21.33M$16.71M$15.37M$13.77M
R&D expense$4.39M$5.26M$5.74M$4.96M$2.47M
SG&A expense$23.38M$21.63M$20.37M$20.61M$17.86M
Operating income-$2.97M-$6.45M-$10.27M-$10.78M-$7.03M
Pretax income-$2.62M-$6.06M-$9.77M-$10.68M-$6.36M
Income tax$21,890$2,893$3.97M-$2.01M-$1.80M
Net income-$2.64M-$6.07M-$13.74M-$8.66M-$4.56M
EBITDA-$2.16M-$5.56M-$9.40M-$10.19M-$6.57M
EPS (basic)-0.06-0.13-0.30-0.19-0.10
EPS (diluted)-0.06-0.13-0.30-0.19-0.10
Weighted avg. shares (diluted)46.19M45.80M45.60M45.00M44.39M
Balance sheet
Cash & equivalents$8.87M$9.58M$11.48M$17.41M$25.33M
Receivables$5.97M$5.72M$4.05M$3.56M$3.59M
Inventory$3.68M$2.80M$3.48M$6.40M$6.11M
Current assets$19.99M$19.13M$20.26M$29.80M$37.32M
PP&E, net$4.47M$4.29M$3.84M$3.89M$1.11M
Intangibles$684,841$730,279$754,361$787,182$808,813
Total assets$28.20M$27.22M$28.46M$42.33M$41.29M
Current liabilities$8.19M$7.20M$4.45M$6.96M$4.79M
Total liabilities$11.15M$10.40M$8.11M$11.01M$4.79M
Shareholders' equity$17.05M$16.81M$20.35M$31.33M$36.50M
Shares outstanding46.37M45.96M45.67M45.44M44.62M
Cash flow statement
Operating cash flow$462,405-$319,718-$4.89M-$5.40M-$4.32M
Capital expenditure$932,517$1.30M$782,949$2.76M$346,178
Free cash flow-$470,112-$1.62M-$5.68M-$8.17M-$4.67M
Investing cash flow-$949,790-$1.33M-$814,597-$2.80M-$366,169
Financing cash flow-$221,350-$248,533-$218,867$279,485$2.71M
Depreciation & amortization$810,500$888,473$870,390$587,137$463,130
Stock-based compensation$2.71M$2.62M$2.77M$3.08M$2.71M

Free plan shows the latest 5 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.